Scientists are excitedly focused on retatrutide, a innovative medication from Eli Lilly, as a significant breakthrough in weight reduction . Unlike many previous approaches, retatrutide is a twin-action receptor targeting simultaneously GLP-1 and GIP, substances that impact appetite and blood sugar